Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
468 |
|
| Actual shortage: | 53 (11%) | |
| Anticipated shortage: | 19 (4%) | |
| Avoided shortage: | 9 (2%) | |
| Resolved: | 387 (83%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
52 (10%) |
|
Overdue reports |
12 (15%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| OXYBUTYNIN | 5MG | TABLET | Resolved | 2017-12-18 | 2019-02-06 | 33667 |
| MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2018-02-21 | 2018-03-14 | 40467 |
| SIMVASTATIN | 5MG | TABLET | Resolved | 2018-07-09 | 2021-05-06 | 54790 |
| MONTELUKAST | 5MG | TABLET (CHEWABLE) | Actual shortage | 2019-02-19 | 2019-04-20 | 76275 |
| OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-03-27 | 2022-08-30 | 79597 |
| MONTELUKAST | 5MG | TABLET (CHEWABLE) | Actual shortage | 2019-04-18 | 2019-04-19 | 81977 |
| SOLIFENACIN | 5MG | TABLET | Resolved | 2019-06-10 | 2019-10-10 | 86061 |
| RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-07-30 | 2019-12-11 | 90221 |
| RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-03-19 | 2020-08-05 | 109008 |
| BISOPROLOL | 5MG | TABLET | Resolved | 2020-03-26 | 2020-03-27 | 109422 |
| TERAZOSIN | 5MG | TABLET | Resolved | 2021-03-10 | 2024-03-02 | 135433 |
| SOLIFENACIN | 5MG | TABLET | Avoided shortage | 2022-04-05 | 2022-10-20 | 157901 |
| TADALAFIL | 5MG | TABLET | Resolved | 2023-07-31 | 2023-12-26 | 200477 |
| SOLIFENACIN | 5MG | TABLET | Resolved | 2023-09-26 | 2023-12-01 | 205212 |
| SOLIFENACIN | 5MG | TABLET | Actual shortage | 2024-01-30 | 2024-05-01 | 217809 |
| RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2024-02-26 | 2024-04-04 | 220668 |
| OXYBUTYNIN | 5MG | TABLET | Actual shortage | 2024-05-28 | 2024-05-28 | 228963 |
| DONEPEZIL | 5MG | TABLET | Actual shortage | 2024-05-28 | 2024-05-28 | 228969 |
| CARVEDILOL | 6.25MG | TABLET | Resolved | 2024-01-30 | 2024-02-13 | 217832 |
| GABAPENTIN | 600MG | TABLET | Resolved | 2020-05-11 | 2020-10-21 | 114770 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-08-12 | 2022-02-06 | 144029 |
| LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-12-16 | 2021-12-17 | 151293 |
| INDAPAMIDE | 2.5MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2450 |
| CILAZAPRIL | 2.5MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4918 |
| FENOFIBRATE MICRO | 200MG | CAPSULE | Discontinued | 2017-08-02 | 2017-08-02 | 17972 |
| DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
| RAMIPRIL-HCTZ | 25.0MG 10.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3026 |
| RAMIPRIL-HCTZ | 25.0MG 5.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3032 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| TERAZOSIN | 2MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151281 |
| CLINDAMYCIN | 300MG | CAPSULE | Reversed | 2017-03-31 | 2017-07-31 | 4956 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| TRAMADOL/ACET | 325MG 37.5MG | TABLET | Discontinued | 2020-04-08 | 2020-07-07 | 111524 |
| RISEDRONATE | 35MG | TABLET | Discontinued | 2024-02-28 | 2024-02-29 | 220861 |
| ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4959 |
| ACYCLOVIR | 400MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4942 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| HYDROXYUREA | 500MG | CAPSULE | Discontinued | 2017-04-03 | 2017-04-03 | 5084 |
| AZATHIOPRINE | 50MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4899 |